A third patient with sickle cell disease (SCD) has been successfully treated in Bahrain using Casgevy, an advanced gene-editing therapy – a further milestone in the kingdom’s development of specialised genetic treatments.The treatment was carried out by the Royal Medical Services (RMS) through the Bahrain Oncology Centre .
